Ajinomoto Bio-Pharma Services Email Format
Pharmaceutical ManufacturingTokio, Japan501-1000 Employees
Ajinomoto Bio-Pharma Services operates as a contract development and manufacturing organization, providing development and manufacturing services to clients. The company is headquartered in Kyobashi, Tokyo, Japan (postal code 104-8315) and has a workforce of 501 to 1000 employees. It runs sites in Belgium, the United States, Japan, and India, offering work across gene therapy, active pharmaceutical ingredients, and both large- and small-molecule manufacturing. The company provides platforms and capabilities for preclinical and pilot programs through to commercial quantities, including Corynex protein expression technology, oligonucleotide synthesis, antibody-drug conjugations, high-potency APIs, biocatalysis, and continuous flow manufacturing. Recent activities include a 2026 collaboration with Piramal Pharma Solutions and a 2025 World ADC Awards recognition for Best ADC Preclinical Publication 2024.